Skip to main content

Rheumatology Therapeutics Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

 


Rheumatology is a branch of medicine dedicated to the diagnosis and therapy of rheumatic diseases. Rheumatology therapeutics involve physical therapies, exercises, and medications with surgical treatment to cure joint damage. Scleroderma, fibromyalgia, gout, osteoarthritis, reactive arthritis, psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis are some common types of rheumatology diseases. Thus, with the increasing burden of rheumatology diseases worldwide, the demand for rheumatology therapeutics is also increasing. According to the Centers for Disease Control and Prevention (CDC), by 2040, around 78 million adults in the United States aged 18 years or older are expected to have doctor-diagnosed arthritis.

The aforementioned factors are expected to augment the rheumatology therapeutics market growth. Moreover, doctors prescribe disease-modifying antirheumatic drugs (DMARDs) for the treatment of rheumatologic disease. For example, in April 2021, Nēsos received the United States Food and Drug Administration (FDA) Breakthrough Device Designation to its digital therapeutic for patients with rheumatoid arthritis (RA) who have had an inadequate response or intolerance to DMARDs. Furthermore, in March 2021, American Rheumatology Network (ARN) launched ARN Clinical Research, a patient centric and real-world technology unit for transforming rheumatology trials and care.

Regional segmentation of rheumatology therapeutics market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates rheumatology therapeutics market, owing to increasing population with rheumatology diseases, changing lifestyle, and established medical and healthcare sector.

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

  Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...
Post a Comment
Read more

Custom Antibody Service Market Segmentation Application, Technology and Market Analysis to 2028

  The immune system produces antibodies in response to pathogen invasion. Antigens are the collective term for the invasive bacteria, viruses, or other foreign molecules. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. It is possible to have antibodies made using custom antibody production when an antibody is required against a particular antigen but it is not offered by a supplier. These antibodies can be either polyclonal or monoclonal, depending on how they are produced and harvested. Polyclonal  antibodies  are capable of recognizing multiple sites on an antigen. They are derived from different B-cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. Global custom antibody service market is estimated to be valued at  US$ 444.85 Million in 2022  and expected to reach  US$ 930.46 million by 2030 , witnessing a  CAGR of 9.7 %  over...
Post a Comment
Read more

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

  Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.  
Post a Comment
Read more